Home > Income Statement > BAL PHARMA

BAL PHARMA
Revenue

    Back to Income Statement
BAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹303 Cr₹339 Cr₹304 Cr₹281 Cr₹251 Cr

What is the latest Revenue of BAL PHARMA ?

The latest Revenue ratio of BAL PHARMA is ₹303 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹303 Cr
Mar2024₹339 Cr
Mar2023₹304 Cr
Mar2022₹281 Cr
Mar2021₹251 Cr

How is Revenue of BAL PHARMA Trending?

Years Revenue % Change
Mar2025 ₹303 Cr
-10.65
Mar2024 ₹339 Cr
11.51
Mar2023 ₹304 Cr
8.18
Mar2022 ₹281 Cr
12.25
Mar2021 ₹251 Cr -

Compare Revenue of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹121.2 Cr -2.9% 12% -26% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹388,680.0 Cr -2.9% -8.9% -3.7% Stock Analytics
DIVIS LABORATORIES ₹168,817.0 Cr 1.2% 4.2% 8.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹139,297.0 Cr -1.7% -3.6% 27.4% Stock Analytics
DR REDDYS LABORATORIES ₹109,828.0 Cr 6.8% 1.3% 13.2% Stock Analytics
CIPLA ₹104,588.0 Cr 5.4% 3.1% -13.6% Stock Analytics


BAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

-2.9%

12%

-26%

SENSEX

-2.3%

3.3%

-2.4%


You may also like the below Video Courses